These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2084237)
21. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Breedveld FC; Weisman MH; Kavanaugh AF; Cohen SB; Pavelka K; van Vollenhoven R; Sharp J; Perez JL; Spencer-Green GT Arthritis Rheum; 2006 Jan; 54(1):26-37. PubMed ID: 16385520 [TBL] [Abstract][Full Text] [Related]
22. Reumacon (CPH82) showed similar x-ray progression and clinical effects as methotrexate in a two year comparative study on patients with early rheumatoid arthritis. Svensson B; Pettersson H Scand J Rheumatol; 2003; 32(2):83-8. PubMed ID: 12737326 [TBL] [Abstract][Full Text] [Related]
23. Time lag between active joint inflammation and radiological progression in patients with early rheumatoid arthritis. Matsuda Y; Yamanaka H; Higami K; Kashiwazaki S J Rheumatol; 1998 Mar; 25(3):427-32. PubMed ID: 9517758 [TBL] [Abstract][Full Text] [Related]
24. Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. A randomized, double-blind study. Jeurissen ME; Boerbooms AM; van de Putte LB; Doesburg WH; Lemmens AM Ann Intern Med; 1991 Jun; 114(12):999-1004. PubMed ID: 2029111 [TBL] [Abstract][Full Text] [Related]
25. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis. Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593 [TBL] [Abstract][Full Text] [Related]
26. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints. Aletaha D; Smolen JS Arthritis Rheum; 2011 Dec; 63(12):3702-11. PubMed ID: 21953215 [TBL] [Abstract][Full Text] [Related]
27. Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis--a randomized, double blind 26-week trial. Morassut P; Goldstein R; Cyr M; Karsh J; McKendry RJ J Rheumatol; 1989 Mar; 16(3):302-6. PubMed ID: 2498513 [TBL] [Abstract][Full Text] [Related]
28. A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: a 12-week, double-blind, randomized, placebo-controlled study. Lan JL; Chou SJ; Chen DY; Chen YH; Hsieh TY; Young M J Formos Med Assoc; 2004 Aug; 103(8):618-23. PubMed ID: 15340661 [TBL] [Abstract][Full Text] [Related]
29. Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study. Detert J; Bastian H; Listing J; Weiß A; Wassenberg S; Liebhaber A; Rockwitz K; Alten R; Krüger K; Rau R; Simon C; Gremmelsbacher E; Braun T; Marsmann B; Höhne-Zimmer V; Egerer K; Buttgereit F; Burmester GR Ann Rheum Dis; 2013 Jun; 72(6):844-50. PubMed ID: 22739990 [TBL] [Abstract][Full Text] [Related]
30. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis. Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904 [TBL] [Abstract][Full Text] [Related]
31. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort. Müller RB; von Kempis J; Haile SR; Schiff MH Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697 [TBL] [Abstract][Full Text] [Related]
33. Radiographic assessment of disease progression in rheumatoid arthritis patients treated with methotrexate or minocycline. Alarcón GS; Bartolucci AA J Rheumatol; 2000 Feb; 27(2):530-4. PubMed ID: 10685828 [TBL] [Abstract][Full Text] [Related]
34. Long term progression of joint damage in rheumatoid arthritis. Scott DL; Coulton BL; Popert AJ Ann Rheum Dis; 1986 May; 45(5):373-8. PubMed ID: 3718010 [TBL] [Abstract][Full Text] [Related]
37. Pulse methotrexate therapy in rheumatoid arthritis. A controlled prospective roentgenographic study. Nordstrom DM; West SG; Andersen PA; Sharp JT Ann Intern Med; 1987 Dec; 107(6):797-801. PubMed ID: 3688672 [TBL] [Abstract][Full Text] [Related]
38. Intra-articular methotrexate. Clinical and laboratory study in rheumatoid and psoriatic arthritis. Hall GH; Jones BJ; Head AC; Jones VE Ann Rheum Dis; 1978 Aug; 37(4):351-6. PubMed ID: 356763 [TBL] [Abstract][Full Text] [Related]
39. Progressive joint damage during penicillamine therapy for rheumatoid arthritis. Scott DL; Greenwood A; Bryans R; Huskisson EC Rheumatol Int; 1988; 8(3):135-9. PubMed ID: 3175451 [TBL] [Abstract][Full Text] [Related]
40. The 'side effects' of rheumatoid arthritis: joint destruction, disability and early mortality. Pincus T; Callahan LF Br J Rheumatol; 1993 Mar; 32 Suppl 1():28-37. PubMed ID: 8448634 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]